Effects of Xanthine Oxidase Inhibitors on Cardiovascular Disease in Patients with Gout: Ascertaining the Efficacy of Treatment Matters

Am J Med. 2015 Sep;128(9):e41-2. doi: 10.1016/j.amjmed.2015.03.029.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Female
  • Gout / drug therapy*
  • Gout Suppressants / therapeutic use*
  • Heart Diseases / etiology*
  • Humans
  • Male
  • Xanthine Oxidase / antagonists & inhibitors*

Substances

  • Gout Suppressants
  • Xanthine Oxidase